Onconetix, Inc. (ONCO)
1.20
+0.03
(+2.56%)
USD |
NASDAQ |
May 29, 16:00
1.22
+0.02
(+1.67%)
Pre-Market: 20:00
Onconetix Profit Margin (Quarterly) : -19.60K% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -57.48% |
| Sensei Biotherapeutics, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 1.36% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| Anika Therapeutics, Inc. | -17.07% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -116.2% |
| Return on Assets | -49.83% |
| Return on Invested Capital | -79.69% |
| Gross Profit Margin (Quarterly) | -7.91% |
| Operating Margin (Quarterly) | -9.73K% |
| Return on Net Operating Assets | -57.19% |